OR WAIT null SECS
© 2023 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
December 02, 2022
A Closing Thought
Regulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.
A roadmap to avoiding the common pitfalls of concurrent FDA-EMA filings.
Summarizing important FDA and EMA revisions issued this year.
Navigating FDA’s draft guidance and heightened diversity recommendations.
Final presentation at DIA reminds: "we are all patients."
Study indentifies trends in most commonly used KRIs.
Nabil Chehab, medical affairs head of lung cancer franchise at AstraZeneca, discuss strategies used in the Phase III AEGEAN trial for treating non-small lung cancer (NSCLC).
View from Brussels
Debates caught between focusing on existing antibiotics and developing new agents.
View from Washington
Looking back on major FDA moves in 2022.
From the Editor
Industry straddling two worlds as new year approaches.
Click the title above for a link to open the Applied Clinical Trials December 2022 issue in an interactive PDF format.
July 13, 2022
Why oncology needs dosing redesign.